awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38812867-040DD8F1-EEB8-4B0E-88B1-94F5C6098DCF
Q38812867-040DD8F1-EEB8-4B0E-88B1-94F5C6098DCF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38812867-040DD8F1-EEB8-4B0E-88B1-94F5C6098DCF
Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms.
P2860
Q38812867-040DD8F1-EEB8-4B0E-88B1-94F5C6098DCF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38812867-040DD8F1-EEB8-4B0E-88B1-94F5C6098DCF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d5d6ac5b8b430e152c362022bdc7b8a46563cf0
P2860
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.